Senate concurs with House amendment to SB 906 allowing prescriptions for FDA-approved psilocybin drugs

The West Virginia Senate concurred with House amendments to Senate Bill 906, which the Clerk described as permitting "lawful prescription of drugs that contain organic psilocybin substance that has received U.S. Food and Drug Administration approval and reschedules by the FDA as being lawful as prescribed, distributed, and marketed." Senator from Lewis urged adoption of the House amendment and the Senate passed the bill by recorded vote (34-0-0) on the floor.

Why it matters: The amendment ties lawful prescription and distribution to FDA approval and any rescheduling the FDA effectuates, which frames state allowance of such products in line with federal regulatory action. The transcript records the floor adoption but does not include statutory text beyond the floor summary.

What's next: The clerk communicated the action to the House. For implementation and clinical-use details reporters should consult the enacted bill text and relevant public-health regulatory guidance.

Quote source: Senator from Lewis (floor remarks).